Sellas Life Sciences Group Inc expected to post a loss of 21 cents a share - Earnings Preview

Sellas Life Sciences

07/05/2024 12:45

* Sellas Life Sciences Group Inc  SLS.OQ   SLS.O  is
expected
to show no change in quarterly revenue when it reports 
results on May 9 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Sellas Life Sciences
Group Inc
is for a loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 103.2% in the last three months. ​
    * Wall Street's median 12-month price target for Sellas Life
Sciences Group Inc is $7.50​, above​ its last closing price
of $1.29. ​​​

This summary was machine generated May 7 at 11:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)